ENTRESTO Drug Profile, 2024: ENTRESTO (sacubitril valsartan) drug patents, FDA exclusivity, litigation, drug prices (DrugPatentWatch Business Intelligence Reports) Paperback – January 9, 2024
Description :
ENTRESTO Drug Profile, 2024This report focuses on ENTRESTO and covers the following critical aspects of this drug:United States patentsDistrict Court patent litigationPatent Trial and Appeal Board (PTAB) patent casesEuropean supplementary protection certificates
(SPCs)Clinical trialsDrug pricesFinished product suppliersRaw active pharmaceutical ingredient (API) sourcesFREE UPDATE: Send your receipt to DrugPatentWatch within 30 days for a free update